Target intelligence / Profile preview

Immune system response to Tetanus toxoid

Molecular classification
Other
01

Overview

The "immune system response to tetanus toxoid" refers to the adaptive immunological processes triggered by vaccination with tetanus toxoid, an inactivated form of tetanus neurotoxin from *Clostridium tetani*. Upon administration, the toxoid is recognized by the immune system, activating T helper cells and B cells, leading to the production of specific antibodies (primarily IgG) that confer protective immunity against subsequent tetanus exposure. Immunological memory is established, but wanes over time, necessitating regular booster vaccinations. The humoral immune response is measured by anti-tetanus antibody titers. Tetanus immune globulin can be given for immediate passive immunity post-exposure, especially in those with inadequate vaccination history[2][3][5][6][7].

Other names
Immune response to tetanus toxoidImmune response to tetanus vaccineTetanus toxoid-induced immunity
02

Mechanism of action

Activation of adaptive immune system (B cells and T cells) by recognition of tetanus toxoid antigens, leading to production of anti-tetanus antibodies and immunological memory; Tetanus immune globulin directly neutralizes circulating tetanus toxin.

03

Biological functions

Immune responseAntibody productionImmunological memory
04

Disease associations

Infection (specifically tetanus prevention)Other
05

Safety considerations

Vaccine side effects including pain, redness, swelling, fever, headache, and fatigueRare allergic reactions or seizures, especially in children
06

Interacting drugs

Tetanus toxoid (vaccine)

1 more in the full profile.

07

Biomarkers

Anti-tetanus antibody titer (used to assess immunity)

Beyond the preview

Go deeper on Immune system response to Tetanus toxoid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system response to Tetanus toxoid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call